These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2496071

  • 1. In-vitro activity of lomefloxacin in comparison with pefloxacin and ofloxacin.
    Van der Auwera P, Grenier P, Glupczynski Y, Pierard D.
    J Antimicrob Chemother; 1989 Feb; 23(2):209-19. PubMed ID: 2496071
    [Abstract] [Full Text] [Related]

  • 2. Antibacterial and plasmid curing activity of lomefloxacin in vitro.
    Derlot E, Poyart-Salmeron C, Courvalin P.
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1048-52. PubMed ID: 2515963
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W.
    Chemotherapy; 1998 Dec; 44(2):77-84. PubMed ID: 9551236
    [Abstract] [Full Text] [Related]

  • 4. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 5. Antibacterial activity of lomefloxacin.
    Leigh DA, Tait S, Walsh B.
    J Antimicrob Chemother; 1991 May; 27(5):589-98. PubMed ID: 1885417
    [Abstract] [Full Text] [Related]

  • 6. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992 May; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 7. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
    Sun ZM, Maskell JP, Sehgal SC, Williams JD.
    Infection; 1989 May; 17(3):165-7. PubMed ID: 2737760
    [Abstract] [Full Text] [Related]

  • 8. [Serum pharmacokinetics and in vitro antibacterial activity of pefloxacin, ofloxacin and ciprofloxacin].
    Nordmann P, Jarlier V.
    Presse Med; 1989 May; 19(28):1321-5. PubMed ID: 2145562
    [Abstract] [Full Text] [Related]

  • 9. The comparative in-vitro activity of pefloxacin.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [Abstract] [Full Text] [Related]

  • 10. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa.
    Aldridge KE, Henderberg A, Sanders CV.
    Diagn Microbiol Infect Dis; 1989 Apr; 12(3 Suppl):1S-6S. PubMed ID: 2507219
    [Abstract] [Full Text] [Related]

  • 11. The comparative in-vitro activity of ofloxacin.
    Grüneberg RN, Felmingham D, O'Hare MD, Robbins MJ, Perry K, Wall RA, Ridgway GL.
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():9-19. PubMed ID: 3182468
    [Abstract] [Full Text] [Related]

  • 12. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
    Aldridge KE, Henderberg A, Gebbia K, Schiro DD, Janney A, Sanders CV.
    Diagn Microbiol Infect Dis; 1989 Sep; 12(3):221-33. PubMed ID: 2791485
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro activity of lomefloxacin (NY-198 or SC 47111).
    Shah PM, Müller S, Kipp J, Stille W.
    Diagn Microbiol Infect Dis; 1989 Sep; 12(3 Suppl):97S-101S. PubMed ID: 2791506
    [Abstract] [Full Text] [Related]

  • 15. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
    Beskid G, Prosser BL.
    Am J Med; 1993 Mar 22; 94(3A):2S-8S. PubMed ID: 8383919
    [Abstract] [Full Text] [Related]

  • 16. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA, Tayeb OS.
    Microbios; 1993 Mar 22; 74(300):147-54. PubMed ID: 8396196
    [Abstract] [Full Text] [Related]

  • 17. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB, Swanson RN.
    Drugs Exp Clin Res; 1988 Mar 22; 14(6):375-8. PubMed ID: 3145851
    [Abstract] [Full Text] [Related]

  • 18. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
    Montanari MP, Prenna M, Mingoia M, Ripa S, Varaldo PE.
    Chemotherapy; 1998 Mar 22; 44(2):85-93. PubMed ID: 9551237
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.